Search results
Results from the WOW.Com Content Network
For perspective, there have been 2,559 cases of dengue fever reported in U.S. states and territories since the start of 2024, per the CDC. A large majority of those (1,724) were reported in Puerto ...
There is no antiviral treatment for dengue fever but symptoms can be managed with certain medications. “There are no vaccines recommended for travelers, adults, or persons without a previous ...
Dengue fever is a mosquito-borne disease caused by dengue virus, prevalent in tropical and subtropical areas. It is frequently asymptomatic ; if symptoms appear they typically begin 3 to 14 days after infection.
So far in 2024, cases of dengue fever in countries in the Americas have reached record-breaking levels, with more than 9.7 million reported cases — twice the number for the entire year in 2023 ...
In contrast, dengue can lead to severe hemorrhagic fever relatively frequently — 1 out of 20 people who are symptomatic — and while a fetus can become infected with dengue too, the result is ...
Dengue virus (DENV) is the cause of dengue fever.It is a mosquito-borne, single positive-stranded RNA virus of the family Flaviviridae; genus Flavivirus. [1] [2] Four serotypes of the virus have been found, and a reported fifth has yet to be confirmed, [3] [4] [5] all of which can cause the full spectrum of disease. [1]
There are currently two dengue vaccines commercially available: Qdenga, which is recommended by the World Health Organization for children aged six to 16 or those living in places with high risk ...
Dengue vaccine is a vaccine used to prevent dengue fever in humans. [9] Development of dengue vaccines began in the 1920s but was hindered by the need to create immunity against all four dengue serotypes. [10] As of 2023, there are two commercially available vaccines, sold under the brand names Dengvaxia and Qdenga. [11] [12]